UBS Group’s Versigent PLC VGNT Stock Holding History

UBS Group’s Portfolio VGNT Stock Details VGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.81M	Buy	233,564 +232,070	+15,533%	+$9.25M	﹤0.01%	3479
2026 Q1	$47.6K	Buy	+1,494	New	+$46.3K	﹤0.01%	7401

Other funds holding VGNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

UBS Group's VGNT Position: Q2 2026 in Review

UBS Group increased its Versigent PLC (VGNT) stake by 15,533% in Q2 2026, buying an estimated $9.25M and bringing the position to 233,564 shares worth $9.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3479.

UBS Group first reported a position in VGNT in Q1 2026 and has held it in 2 quarters since. 434 funds tracked by Wall St. Rank hold VGNT as of Q2 2026.

UBS Group held 233,564 shares of Versigent PLC worth $9.81M as of Q2 2026.
UBS Group bought 232,070 Versigent PLC shares in Q2 2026, an estimated $9.25M.
Versigent PLC made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3479 holding.
UBS Group first reported a position in Versigent PLC in Q1 2026 and has held it in 2 quarters since.
434 funds tracked by Wall St. Rank held Versigent PLC as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.